Atara Biotherapeutics, Inc. (LON:0HIY)
London · Delayed Price · Currency is GBP · Price in USD 13.23
-0.97 (-6.84%)
At close: Nov 4, 2025
Atara Biotherapeutics Market Cap
Atara Biotherapeutics has a market cap or net worth of 63 million as of November 7, 2025. Its market cap has increased by 69.65% in one year.
Market Cap
63.00M
Enterprise Value
59.47M
Revenue
137.71M
Ranking
n/a
PE Ratio
14.89
Stock Price
13.23
Market Cap Chart
Since October 17, 2014, Atara Biotherapeutics's market cap has decreased from 144.86M to 63.00M, a decrease of -56.51%. That is a compound annual growth rate of -7.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 63.00M | 2.88% |
| Dec 31, 2024 | 61.24M | 49.24% |
| Dec 29, 2023 | 41.03M | -84.11% |
| Dec 30, 2022 | 258.28M | -74.90% |
| Dec 31, 2021 | 1.03B | -13.57% |
| Dec 31, 2020 | 1.19B | 76.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 199.02B |
| GSK plc | 71.49B |
| Haleon | 31.93B |
| Smith & Nephew | 10.53B |
| ConvaTec Group | 4.64B |
| Hikma Pharmaceuticals | 3.37B |
| HUTCHMED (China) | 1.98B |
| Genus | 1.60B |